A Study of Pevonedistat in Adult East Asian Participants
Status:
Active, not recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of pevonedistat
administered as a single agent and in combination with azacitidine in adult east Asian
participants with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).